• No results found

ARMENIA. Albert Matevosyan MD,PhD

N/A
N/A
Protected

Academic year: 2021

Share "ARMENIA. Albert Matevosyan MD,PhD"

Copied!
16
0
0

Loading.... (view fulltext now)

Full text

(1)

Albert Matevosyan MD,PhD

“Neurohereditary Diseases” Charity Association

Head of Republic Center of Medical Genetic and Department of Medical Genetic Yerevan State Medical University

(2)

Istituto Superiore di Sanità Istituto Superiore di Sanità

Information about rare diseases

Neuromuscular and neurodegenerative diseases (myodystrophy, spinal and neural amyotrophy, myotonia, hereditary ataxia and

subcortical degeneration), more than 45 types - 836 patients from З45 families (database of RCMG).

Phenylketonuria (57 patients - database of RCMG).

Congenital Hypothyroidism (36 patients - database of MC “Arabkir”).

Mucopolysaccharidosis (14 patients - database of RCMG).

Cystic Fibrosis (30 patients - database of RUCM).

Williams Syndrome (5 patients - database of RCMG).

Congenital malformations (120 patients - database of RCMCHP).

Chromosomal syndromes (more 220 patients - database ACAG).

Mediterranean fever (for Armenia it’s not Rare disease) 2-3:1000 people.

Other forms of rare diseases - described more than 60 forms.

(3)

Education about rare diseases

Annual scientific conferences and seminars for practical doctors of Yerevan and republic rsegions(from 5 to 12 meetings per year).

Learning program in postgraduate education for family doctors (the last 7 years).

Educational program and learning of students of medical university.

Prepared web-site: www.nhd-mda.am.

Preparation and distribution of booklets and new information about RD from our European collaborating organizations (EURORDIS, ICRD,

IPWSO, ENMC).

it is prepared a photo- and a video data on RD for the teaching course for doctors and students (thousands photos and video materials).

In 2008 the Project on Prader-Willi Syndrome was executed by support IPWSO and Lyncy fund (USA)

(4)

Istituto Superiore di Sanità Istituto Superiore di Sanità

Diagnostics of rare diseases

Governmental program of neonatal screening on PKU (since 2008) .

Governmental program of neonatal screening of congenital hypothyroidism (since 2005).

Diagnosis of neuromuscular and neurodegenerative diseases (biochemical examination, EMG, EEG, NMR etc.).

DNA diagnosis of Mediterranean fevers and cystic fibrosis.

Cytogenetic examination (karyotyping and FISH).

Prenatal and neonatal screening (ultrasound, biochemical screening) in 2 leading medical centers.

Collaboration with foreign laboratories and centers for DNA and other examination of patients RD (Switzerland, Italy,

Germany, Russia etc).

(5)

Treatment patients with rare diseases

Patients with hypothyroidism, cystic fibrosis and mediterranean fever are completely provided by medical drugs.

Patients with phenylketonuria receive free of charge medical dietary mixes.

Patients with blood diseases (hemophilia and leucosis) are to some extent provided by treatment.

There are no drugs for patients with mucopolysaccharidosis.

There aren’t specialized and rehabilitation centers for patients with neuromuscular and neurodegenerative diseases.

Problems with provision Orphan drugs and regular provision diet mixes for PKU

(6)

Istituto Superiore di Sanità Istituto Superiore di Sanità

Rehabilitation of Rare diseases

Rehabilitation patients with rare diseases is carried out in three rehabilitation centers and in the different children hospitals.

In republic there are more than 20 centers for different form diseases.

But unfortunately we do not have specialized centers for separate form of the diseases: neuromuscular diseases, phenylketonuria etc.

Functioning and specialized centre of expertise for

phenylketonuria, mucopolysaccharidosis, neuromuscular diseases and chromosomal syndromes is the Republic Centre of Medical Genetics.

Joint Medical Center & Institute of Child and Adolescent Health provide monitoring and treatment of Hypothireodism and other Rare diseases.

(7)

Prevention of rare diseases

Prescribing of the folic acid to all pregnant woman.

Ultrasound screening all pregnant woman.

Governmental program of neonatal screening on PKU.

Governmental program of neonatal screening

on congenital hypothyroidism.

Prenatal diagnosis of some metabolic diseases,

chromosomal syndromes and malformations.

(8)

Istituto Superiore di Sanità Istituto Superiore di Sanità

Available orphan drugs in the country

In 2008 the Ministry of Health approval “The list of vital important drugs” where are included 83 drugs.

Patients with congenital hypothyroidism, cystic fibrosis are provided with drugs, patient with PKU - with special mixes.

At the present time we support list of orphan drugs for treatment patients with mucopolysaccharidosis.

We are planning to:

Prepare and enlarge List of Orphan drugs for registration by the Ministry of Health.

Assist introduction and providing diet food for patients with RD (phenylketonuria).

Collaborate with pharmaceutical industry for providing patients with RD by Orphan drugs.

Collaborate with International centres and organizations.

(9)

Rare diseases patient organizations ...

At the present time in republic actively work:

“Neurohereditary Diseases” Association (created in1992)

“Hemophilia” Association (created in 2000)

“Alzheimer’s disease” Association (created in 2002)

After I South Caucasian conference was organized Armenian Alliance of Rare Diseases (created in 2010)

And now we enlarge our Alliance and begin involving new

organizations. We suggest to be Honor president of this Alliance, of Chairman of the parliament commission on the issues of

health care, director of Institute child and adolescent prof. Babloyan A.,which has given one's consent.

(10)

Istituto Superiore di Sanità Istituto Superiore di Sanità

Aim of National Plan for rare diseases

(preliminary project)

 

The aim of the program is to create a uniform

national health policy, ensuring the citizens of

Republic of Armenia with prevention, timely

diagnosis, adequate treatment and rehabilitation

of rare diseases

.

(11)

Priorities

(preliminary project)

 

Institutional framework and mechanisms

Epidemiological data

Newborn screening

Treatment Orphan Drugs

Training of medical students and doctors

Scientific work and research

National awareness campaign

Support of patient associations

Collaboration with other EU member states

National network of Rare Diseases

Creatad moderm laboratory basis  

(12)

Istituto Superiore di Sanità Istituto Superiore di Sanità

National plan on rare diseases in Armenia

(Previously project)

 Information and Education.

 Detection, diagnosis and registration RD, creation of National database and registers for RD.

 Enlarge newborn screening on PKU, congenital hypothyroidism and other disorders all over Republic.

 Creation of National list of Orphan drugs.

 Providing to patients with RD new treatment methods and Orphan drugs.

 Creation Center Expertise and rehabilitation centers for Neuromuscular and metabolic diseases.

 Activity on enlarge of number of patients organization.

 Creation the Information communication network on RD.

 In focus of the Program: PKU, congenital hypothyroidism, cystic fibrosis,

mucopolysaccharidosis, neuromuscular and neurodegenerative disease, Prader-Willi syndrome, and other RD.

 The Annual Conference on program National plan strategy of RD. The program is planned for 10 years.

(13)

How EUROPLAN can support us?

 Help in the methodology of research, unification and standardization by creation of the database and registers RD.

 Providing information materials.

 Exchange of experience of participants of the project of EUROPLAN.

 To help with the organization of trainings and meeting with our doctors and patients representatives.

 Informing and acquaintance government agencies and bodies of public health services of our republic about the EUROPLAN, and European Union initiatives, realization of National plans on RD.

Looking up foundation, grants and opportunity for financing research

(14)

Istituto Superiore di Sanità Istituto Superiore di Sanità

28 February - Rare Diseases

Day

(15)
(16)

Istituto Superiore di Sanità Istituto Superiore di Sanità

Thank you for

collaboration and

participation

in EUROPLAN team !

References

Related documents

CNP subtype: Classical-neural-proneural subtype; CSC: Cancer stem cell; ECAR: Extracellular acidification rate; G6P: Glucose 6-phosphate; GBM: Glioblastoma; GDH:

[r]

Elaborating intent shows how emphasis on scientific origins of detection kits, and scientific justification for UID tagging in increasing dairy productivity

C) Demonstrated feasibility of automated processing for data mining space based imagery for applications of military interest.. FEASIBILITY DOCUMENTATION: Offerors interested

Michael Horan, Insurance Ireland with speakers Stephen Dalton, Head of Intelligence, Insurance Fraud Bureau, UK, David Fitzgerald, Head of Claims, Allianz Ireland, Michael O

For the success of the strategies, the country designs and continuing implementing Agricultural Development Led Industrialization (ADLI) to attain a high nutritional

The total static dipole moment (μ), the anisotropy of the polarizability Δα, the mean polarizability α and the mean first-order hyperpolarizability (β) of the molecule

The study comprises three component parts; local HES data analysis, case studies examining the emergency hospital admission activity of a local nursing home and